| pubmed-article:17154177 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17154177 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:17154177 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:17154177 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
| pubmed-article:17154177 | lifeskim:mentions | umls-concept:C0005516 | lld:lifeskim |
| pubmed-article:17154177 | lifeskim:mentions | umls-concept:C0038952 | lld:lifeskim |
| pubmed-article:17154177 | lifeskim:mentions | umls-concept:C0050078 | lld:lifeskim |
| pubmed-article:17154177 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:17154177 | pubmed:dateCreated | 2007-1-25 | lld:pubmed |
| pubmed-article:17154177 | pubmed:abstractText | 8-Hydroxy-2'-deoxyguanosine (8-OH-dG) is 1 of the most abundant oxidative products of cellular DNA. Accumulation of impaired 8-OH-dG could lead to increased genomic instability that in turn could lead to a more malignant phenotypic behavior of tumors. Therefore, the effects of 8-OH-dG on survival in 99 resected nonsmall-cell lung cancer (NSCLC) patients was evaluated. | lld:pubmed |
| pubmed-article:17154177 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17154177 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17154177 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:17154177 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17154177 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17154177 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17154177 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17154177 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17154177 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17154177 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17154177 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:17154177 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:17154177 | pubmed:author | pubmed-author:ShenJieJ | lld:pubmed |
| pubmed-article:17154177 | pubmed:author | pubmed-author:ZhaoHuaH | lld:pubmed |
| pubmed-article:17154177 | pubmed:author | pubmed-author:HuntJay DJD | lld:pubmed |
| pubmed-article:17154177 | pubmed:author | pubmed-author:DeiningerPres... | lld:pubmed |
| pubmed-article:17154177 | pubmed:copyrightInfo | (c) 2007 American Cancer Society. | lld:pubmed |
| pubmed-article:17154177 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17154177 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:17154177 | pubmed:volume | 109 | lld:pubmed |
| pubmed-article:17154177 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17154177 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17154177 | pubmed:pagination | 574-80 | lld:pubmed |
| pubmed-article:17154177 | pubmed:meshHeading | pubmed-meshheading:17154177... | lld:pubmed |
| pubmed-article:17154177 | pubmed:meshHeading | pubmed-meshheading:17154177... | lld:pubmed |
| pubmed-article:17154177 | pubmed:meshHeading | pubmed-meshheading:17154177... | lld:pubmed |
| pubmed-article:17154177 | pubmed:meshHeading | pubmed-meshheading:17154177... | lld:pubmed |
| pubmed-article:17154177 | pubmed:meshHeading | pubmed-meshheading:17154177... | lld:pubmed |
| pubmed-article:17154177 | pubmed:meshHeading | pubmed-meshheading:17154177... | lld:pubmed |
| pubmed-article:17154177 | pubmed:meshHeading | pubmed-meshheading:17154177... | lld:pubmed |
| pubmed-article:17154177 | pubmed:meshHeading | pubmed-meshheading:17154177... | lld:pubmed |
| pubmed-article:17154177 | pubmed:meshHeading | pubmed-meshheading:17154177... | lld:pubmed |
| pubmed-article:17154177 | pubmed:meshHeading | pubmed-meshheading:17154177... | lld:pubmed |
| pubmed-article:17154177 | pubmed:meshHeading | pubmed-meshheading:17154177... | lld:pubmed |
| pubmed-article:17154177 | pubmed:meshHeading | pubmed-meshheading:17154177... | lld:pubmed |
| pubmed-article:17154177 | pubmed:meshHeading | pubmed-meshheading:17154177... | lld:pubmed |
| pubmed-article:17154177 | pubmed:meshHeading | pubmed-meshheading:17154177... | lld:pubmed |
| pubmed-article:17154177 | pubmed:meshHeading | pubmed-meshheading:17154177... | lld:pubmed |
| pubmed-article:17154177 | pubmed:meshHeading | pubmed-meshheading:17154177... | lld:pubmed |
| pubmed-article:17154177 | pubmed:meshHeading | pubmed-meshheading:17154177... | lld:pubmed |
| pubmed-article:17154177 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17154177 | pubmed:articleTitle | 8-Hydroxy-2'-deoxyguanosine (8-OH-dG) as a potential survival biomarker in patients with nonsmall-cell lung cancer. | lld:pubmed |
| pubmed-article:17154177 | pubmed:affiliation | Department of Epidemiology, Division of Cancer Prevention and Population Science, Roswell Park Cancer Institute, Buffalo, New York 14263, USA. | lld:pubmed |
| pubmed-article:17154177 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17154177 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17154177 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17154177 | lld:pubmed |
